• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NeuroOne Medical Technologies Corporation - Common Stock (NQ:NMTC)

    0.9925 -0.0075 (-0.75%)
    Delayed Quote Updated: 12:27 PM EDT, Oct 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 25,832
    Open 1.030
    Bid (Size) 0.9700 (700)
    Ask (Size) 0.9999 (200)
    Prev. Close 1.000
    Today's Range 0.9649 - 1.030
    52wk Range 0.9500 - 6.120
    Shares Outstanding 12,000,585
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology
    From NeuroOne Medical Technologies Corporation
    Via GlobeNewswire
    News headline image
    NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
    From NeuroOne Medical Technologies Corporation
    Via GlobeNewswire

    Performance

    52-Week Range 83.8% below 52-week high
    0.9925
    0.9552W Low 6.1252W High
    1 Week 12.9% below 1-week high
    0.951W Low 1.141W High

    NeuroOne Medical Technologies Corporation - Common Stock (NMTC) traded between $0.95 and $6.12 over the past 52 weeks and last traded at $0.99, 83.8% below its 52-week high. Over the past week it ranged between $0.95 and $1.14.

    Past 12 Months
    -9.8%
    -23.7%
    -54.1%
    -80.1%
    -80.6%
    -80.1%
    1W -$0.11
    1M -$0.31
    3M -$1.17
    6M -$3.99
    YTD -$4.12
    1Y -$3.99

    NMTC was -80.1% over the past year, -80.1% over six months, -80.6% year to date, -9.8% in the last week.

    12 Months vs Market
    NMTC
    -80.1%
    DIA
    +12.1%
    SPY
    +14.5%
    QQQ
    +17.4%
    IWM
    +10.9%

    Over the past 12 months NMTC returned -80.1% versus DIA (Dow) +12.1%, SPY (S&P 500) +14.5%, QQQ (Nasdaq 100) +17.4% and IWM (Russell 2000) +10.9%.

    Volume & Liquidity 0.08× 3-mo avg
    Today 25,832 3-mo avg 334.1K
    1W
    91.1K
    1M
    167.8K
    3M
    334.1K
    6M
    190.1K
    YTD
    137.6K
    1Y
    117.3K

    NMTC most recently traded 25,832 shares against a 3-month average daily volume of 334.1K.

    More News

    Read More
    News headline image
    NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement
    From NeuroOne Medical Technologies Corporation
    Via GlobeNewswire
    BioMedNewsBreaks — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Completes Three Large-Animal Procedures Using StereoCED(TM) Platform
    Via Investor Brand Network
    NeuroOne (NMTC) Q2 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform
    Via NewMediaWire
    News headline image
    NeuroOne (NMTC) Q3 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9%
    Via NewMediaWire
    Topics Supply Chain
    News headline image
    NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification
    Via NewMediaWire
    News headline image
    NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time
    Via NewMediaWire
    Topics Earnings
    News headline image
    NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED(TM) Platform
    Via NewMediaWire
    News headline image
    NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians
    Via NewMediaWire
    News headline image
    NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial
    Via NewMediaWire
    News headline image
    NeuroOne(R) Added to Russell Microcap(R) Index
    Via NewMediaWire
    NeuroOne(R) Added to Russell Microcap(R) Index
    Via TheNewswire.com
    News headline image
    NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Via NewMediaWire
    NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Via TheNewswire.com
    NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index
    Via TheNewswire.com
    News headline image
    NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index
    Via NewMediaWire
    NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time
    Via TheNewswire.com
    News headline image
    NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time
    Via NewMediaWire
    News headline image
    NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026
    Via NewMediaWire
    NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026
    Via TheNewswire.com
    News headline image
    NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
    Via NewMediaWire
    NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
    Via TheNewswire.com

    Frequently Asked Questions

    Is NeuroOne Medical Technologies Corporation - Common Stock publicly traded?
    Yes, NeuroOne Medical Technologies Corporation - Common Stock is publicly traded.
    What exchange does NeuroOne Medical Technologies Corporation - Common Stock trade on?
    NeuroOne Medical Technologies Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for NeuroOne Medical Technologies Corporation - Common Stock?
    The ticker symbol for NeuroOne Medical Technologies Corporation - Common Stock is NMTC on the Nasdaq Stock Market
    What is the current price of NeuroOne Medical Technologies Corporation - Common Stock?
    The current price of NeuroOne Medical Technologies Corporation - Common Stock is 0.9925
    When was NeuroOne Medical Technologies Corporation - Common Stock last traded?
    The last trade of NeuroOne Medical Technologies Corporation - Common Stock was at 10/20/26 12:27 PM ET
    What is the market capitalization of NeuroOne Medical Technologies Corporation - Common Stock?
    The market capitalization of NeuroOne Medical Technologies Corporation - Common Stock is 11.91M
    How many shares of NeuroOne Medical Technologies Corporation - Common Stock are outstanding?
    NeuroOne Medical Technologies Corporation - Common Stock has 12M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.